Emiliano Calvo
MD PhD
Director, START Madrid
👥Biography 个人简介
Emiliano Calvo at START Madrid has been a leader in European early-phase cancer clinical trials, contributing to first-in-human studies of immunotherapy combinations with targeted therapies. His work evaluating combinations of checkpoint inhibitors with CDK4/6 inhibitors, PI3K inhibitors, and other targeted agents explores potential synergies between targeted pathway inhibition and anti-tumor immunity that may overcome resistance mechanisms.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Emiliano Calvo 的研究动态
Follow Emiliano Calvo's research updates
留下邮箱，当我们发布与 Emiliano Calvo（Centro Integral Oncologico Clara Campal）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment